Nanovibronix Inc Stock Price, News & Analysis

NanoVibronix, Inc. (NASDAQ: NAOV) has signed a Provider Agreement with EZ Health Care, integrating into the EZ Workers’ Comp Network. This agreement aims to simplify the claims and reimbursement process for healthcare providers using PainShield under workers' compensation plans. CEO Brian Murphy stated that partnering with EZ Health Care will enhance PainShield's accessibility and promote non-opioid pain management.

With a focus on low-intensity surface acoustic wave technology, NanoVibronix continues to innovate in non-invasive pain relief solutions.

NanoVibronix, Inc. (NASDAQ: NAOV) has entered into an International Marketing, Sales and Clinical Management Agreement with Medtech Solutions Group (MTSG), enabling MTSG to sell the company's UroShield® and PainShield® devices across Europe, Asia Pacific, Africa, Central and South America, and parts of the Middle East, excluding specific countries.

This strategic partnership is poised to significantly expand NanoVibronix's market reach, potentially benefiting millions of patients and driving international revenue growth.

NanoVibronix Inc (NASDAQ: NAOV) has filed three patent applications with the U.S. Patent & Trademark Office aimed at expanding its portfolio of Surface Acoustic Wave (SAW) technology for medical devices. CEO Brian Murphy highlighted innovations including new applications in cosmetic dermatology, targeting a growing market. The patents also address enhancements to indwelling medical devices, contributing to infection prevention, a major healthcare concern. The implications of these developments could lead to new product launches and improvements, significantly impacting the company's market position.

NanoVibronix Inc. (NASDAQ: NAOV) announced the appointment of Aurora (Rori) Cassirer and Maria (Lulu) Schroeder as independent directors, effective immediately. This expands the board to eight members, six of whom are independent under Nasdaq rules. Cassirer brings over 30 years of legal and corporate governance expertise, while Schroeder offers significant financial experience from her previous roles, including CFO at Brain Sentinel. The company believes these appointments will enhance its strategic initiatives and support its growth in the medical device market.

NanoVibronix Inc. (NASDAQ: NAOV), a medical device company, will present at the H.C. Wainwright BioConnect Virtual Conference from January 10-13, 2022. CEO Brian Murphy will discuss the company's business and products, including the UroShield® and PainShield® devices, which utilize surface acoustic wave technology for therapeutic applications. The presentation will be available online starting on January 10 at 7 AM ET, with a recording accessible for 90 days. For registration, visit the conference link.

NanoVibronix Inc (NASDAQ: NAOV) has partnered with Delta Medical to distribute its PainShield devices to Veterans Administration (VA) facilities. This collaboration, facilitated by Applied Medical Solutions, aims to enhance sales of PainShield products across over 1700 targeted VA locations. Delta Medical, led by veteran Justin A. Brooks, has a unique focus on non-opioid treatments for chronic pain management. PainShield aims to address veterans’ pain effectively while minimizing risks associated with opioid use.

NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company, has signed a two-year agreement with Applied Medical Solutions to distribute its PainShield products to Veterans Administration facilities across the U.S. CEO Brian Murphy highlighted the opportunity to serve nine million veterans annually, emphasizing the growing demand for non-opioid pain management solutions. Initial sales indicate strong adoption within select VA facilities, which could positively impact revenue in the upcoming quarters. PainShield is an ultrasound device designed for pain treatment and soft tissue healing, enabling patient use at home or work.

NanoVibronix, Inc. (NASDAQ: NAOV) announced that its Special Meeting of Stockholders, initially set for December 21, 2021, has been adjourned due to a lack of quorum and will reconvene on December 29, 2021. During this period, the company will solicit proxies from stockholders regarding proposals in the proxy statement. Stockholders can vote online or by phone until December 28, 2021. NanoVibronix specializes in noninvasive medical devices targeting wound healing and pain therapy using ultrasound technology.

NanoVibronix Inc. (NASDAQ: NAOV) has announced the commencement of sales in Europe following a distribution agreement with Medina Healthcare Ltd in Malta. This partnership aims to leverage Medina's distribution capabilities to penetrate the European market. The company has regulatory approval to sell its products, including UroShield and PainShield, which address healthcare needs such as preventing infections and managing chronic pain. The initial order from Medina signifies confidence in NanoVibronix's technology and market potential.